SynthesisJournal of neurology2024

Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis.

Julian Hirt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.